Skip to main content
SpringerLink
Log in

The Use of Drug-Coated Balloons for Patients with In-Stent Restenosis

  • Chapter
  • First Online:
Drug-Coated Balloons

  • 495 Accesses

Abstract

Most of the evidence supporting the efficacy and clinical value of drug-coated balloons (DCB) has been generated in patients suffering from in-stent restenosis (ISR) [1]. Other scenarios for the use of DCB include small vessels, diffuse disease, and coronary bifurcation where the systematic implantation of a stent is not very attractive or is associated with adverse clinical and angiographic results. Information on the value of DCB in these settings is mainly based in observational registries or small clinical trials. Some studies also suggest that DCB may be of value in patients with acute myocardial infarction, a complex scenario associated with plaque rupture and a large thrombus burden where the acute results of stent implantation may not be optimal. At last DCB have been used in selected de novo lesions providing satisfactory angiographic results obtained upon dilatation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Alfonso F, Byrne RA, Rivero F, Kastrati A. Current treatment of in-stent restenosis. J Am Coll Cardiol. 2014;63:2659–73.

    Article  Google Scholar 

  2. Scheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 2006;355:2113–24.

    Article  CAS  Google Scholar 

  3. Scheller B, Clever YP, Kelsch B, et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc Interv. 2012;5:323–30.

    Article  Google Scholar 

  4. Unverdorben M, Vallbracht C, Cremers B, et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation. 2009;119:2986–94.

    Article  CAS  Google Scholar 

  5. Scheller B, Fontaine T, Mangner N, et al. A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: results from the multi-center randomized controlled PATENT-C first in human trial. Catheter Cardiovasc Interv. 2016;88(1):51–9.

    Article  Google Scholar 

  6. Alfonso F, Pérez-Vizcayno MJ, Cárdenas A, et al. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis intra-stent of bare metal stents: paclitaxel-eluting balloon vs. everolimus-eluting stent). J Am Coll Cardiol. 2014;63:1378–86.

    Article  CAS  Google Scholar 

  7. Alfonso F, Pérez-Vizcayno MJ, García Del Blanco B, et al. Long-term results of everolimus-eluting stents versus drug-eluting balloons in patients with bare-metal in-stent restenosis: 3-year follow-up of the RIBS V clinical trial. JACC Cardiovasc Interv. 2016;9:1246–55.

    Article  Google Scholar 

  8. Adriaenssens T, Dens J, Ughi G, Bennett J, et al. Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomized clinical trial. EuroIntervention. 2014;10:439–48.

    Article  Google Scholar 

  9. Pleva L, Kukla P, Kusnierova P, Zapletalova J, Hlinomaz O. Comparison of the efficacy of paclitaxel-eluting balloon catheters and everolimus-eluting stents in the treatment of coronary in-stent restenosis: the treatment of in-stent restenosis study. Circ Cardiovasc Interv. 2016;9:e003316.

    CAS  PubMed  Google Scholar 

  10. Habara S, Mitsudo K, Kadota K, et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc Interv. 2011;4:149–54.

    Article  Google Scholar 

  11. Rittger H, Brachmann J, Sinha AM, et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol. 2012;59:1377–82.

    Article  CAS  Google Scholar 

  12. Xu B, Gao R, Wang J, et al. A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial. JACC Cardiovasc Interv. 2014;7:204–11.

    Article  Google Scholar 

  13. Byrne RA, Neumann FJ, Mehilli J, et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet. 2013;381:461–7.

    Article  CAS  Google Scholar 

  14. Kufner S, Joner M, Schneider S, et al. Neointimal modification with scoring balloon and efficacy of drug-coated balloon therapy in patients with restenosis in drug-eluting coronary stents: a randomized controlled trial. JACC Cardiovasc Interv. 2017;10(13):1332–40.

    Article  Google Scholar 

  15. Alfonso F, Pérez-Vizcayno MJ, Cárdenas A, et al. A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the ribs iv randomized clinical trial. J Am Coll Cardiol. 2015;66:23–33.

    Article  CAS  Google Scholar 

  16. Siontis GC, Stefanini GG, Mavridis D, et al. Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis. Lancet. 2015;386:655–64.

    Article  Google Scholar 

  17. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35:2541–619.

    Article  Google Scholar 

  18. Wöhrle J, Zadura M, Möbius-Winkler S, et al. SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study. J Am Coll Cardiol. 2012;60(18):1733–8.

    Article  Google Scholar 

  19. Habara S, Iwabuchi M, Inoue N, et al. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. Am Heart J. 2013;166:527–533.e2.

    Article  CAS  Google Scholar 

  20. Habara S, Kadota K, Shimada T, et al. Late restenosis after paclitaxel-coated balloon angioplasty occurs in patients with drug-eluting stent restenosis. J Am Coll Cardiol. 2015;66:14–22.

    Article  Google Scholar 

  21. Alfonso F, Pérez-Vizcayno MJ, García Del Blanco B, et al. Usefulness of drug-eluting balloons for bare-metal and drug-eluting in-stent restenosis (from the RIBS IV and V randomized trials). Am J Cardiol. 2017;119:983–90.

    Article  Google Scholar 

  22. Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol. 2011;57:1314–22.

    Article  CAS  Google Scholar 

  23. Sandoval J, Medina M, Alfonso F. Neointimal tissue healing patterns after paclitaxel-eluting balloon treatment of in-stent restenosis: optical coherence tomography and intravascular ultrasound insights. J Invasive Cardiol. 2012;24:E215–8.

    PubMed  Google Scholar 

  24. Agostoni P, Belkacemi A, Voskuil M, Nathoe HM, Doevendans PA, Stella PR. Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: mechanisms of action evaluated with angiography, optical coherence tomography, and fractional flow reserve. JACC Cardiovasc Interv. 2013;6(6):569–76.

    Article  Google Scholar 

  25. Byrne RA, Joner M, Alfonso F, Kastrati A. Drug-coated balloon therapy in coronary and peripheral artery disease. Nat Rev Cardiol. 2014;11:13–23.

    Article  CAS  Google Scholar 

  26. Hamm CW. Drug-coated balloons for the treatment of coronary in-stent restenosis: a randomised, multicenter, controlled clinical study. Presented at PCR 2017.

    Google Scholar 

  27. Alfonso F, Jimenez-Quevedo P, Gonzalo N, Medina M, Bañuelos C. Neoatherosclerosis after paclitaxel-coated balloon angioplasty for in-stent restenosis. Circulation. 2014;129:923–5.

    Article  Google Scholar 

  28. Alfonso F, Cuesta J, Pérez-Vizcayno MJ, et al. Bioresorbable vascular scaffolds for patients with in-stent restenosis: the RIBS VI study. JACC Cardiovasc Interv. 2017;10:1841–51.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Hospital Universitario La Princesa, Instituto Investigacion Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, Madrid, Spain

    Fernando Alfonso, Javier Cuesta, Fernando Rivero, Marcos García Guimaraes & Teresa Bastante

  2. Cardiac Department, San Carlo Clinic, Milano, Italy

    Bernardo Cortese

Authors
  1. Fernando Alfonso
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Javier Cuesta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fernando Rivero
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marcos García Guimaraes
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Teresa Bastante
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bernardo Cortese
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cardiac Department, San Carlo Clinic, Milano, Italy

    Bernardo Cortese

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Alfonso, F., Cuesta, J., Rivero, F., Guimaraes, M.G., Bastante, T., Cortese, B. (2019). The Use of Drug-Coated Balloons for Patients with In-Stent Restenosis. In: Cortese, B. (eds) Drug-Coated Balloons . Springer, Cham. https://doi.org/10.1007/978-3-319-92600-1_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-92600-1_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-92599-8

  • Online ISBN: 978-3-319-92600-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation